MEDS Income Statement


* In Millions (except for per share items) of USD
Period Ending: LTM
(Last Twelve Months)
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2008
12-31
2007
12-31
2006
12-31
Report Filing: 2024-04-22 2023-03-27 2022-03-28 2021-03-29 2020-03-30 2019-03-22 2018-03-02 2017-03-30 2016-03-28 2015-03-23 2013-12-31 2012-12-31 2009-04-15 2008-03-28 2006-12-31
Revenue 8272214 11448265 9889433 17122520 7436264 3831778 2931280 2481866 4992203 1496227 955881 806047 0 0 0
Cost of Revenue 5673957 5997049 5143468 11415198 2565500 449049 0 16362 1928067 440047 944070 689808 0 0 0
Gross Profit 2598257 5451216 4745965 5707322 4870764 3382729 2931280 2465504 3064136 1056180 11811 116239 0 0 0
Operating Expenses 9861663 8207761 10038258 7488011 4304945 3470345 2536185 3449533 4051183 2487652 2095815 266952 28497000 28186 8725
Research & Development 1376908 1160856 1367895 662726 647140 949948 0 0 0 0 0 198406 0 0 3565
Selling, General and Administrative 8484755 7046905 8811832 7488011 4377020 2350569 2268350 3449533 4051183 2487652 2095815 266952 28497000 24771 5160
Other Operating Expenses 0 0 -141469 -662726 -719215 169828 267835 0 0 0 0 -198406 0 3415 0
Operating Income -7263406 -2756545 -5292293 -1780689 565819 -87616 395095 -984029 -987047 -1431472 -2084004 -150713 -28497000 -28186 -8725
Net Interest(Non Operating) -1194148 -315217 0 0 0 -57541 -157056 -151500 -130136 -4154 -7281 0 0 0 0
Interest Income 4198 20989 23590 29389 53227 0 0 0 0 0 0 0 0 0 0
Interest Expense 1198346 336206 23590 29389 53227 57541 157056 151500 130136 4154 7281 0 0 0 0
Equity & Other Income/(Expense) -5262992 -838106 -23590 -755362 -850247 154195 50944 -37579 0 -576417 0 0 28468504 28186 8725
Income Before Tax -13720546 -3909868 -5315883 -2536051 -284428 9038 288983 -1173108 -1117183 -2012043 -2091285 -150713 -28496 0 0
Income Tax Expense 5335917 400337 -1202836 29389 125302 -154195 -50944 1624596 130136 576417 7281 0 28497000 28186 8725
Income Attributable to Non-Controlling Interest -1212889 0 0 0 0 154195 50944 -37579 -130136 -576417 -7281 0 -28496 0 0
Net Income -17843574 -4310205 -4113047 -2565440 -409730 9038 288983 -2760125 -1117183 -2012043 -2091285 -150713 -28497000 -28186 -8725
Depreciation and Amortization 1049830 216844 138909 102520 94731 331467 335335 0 3802 4800 3987 2625 0 0 0
EBITDA -6213576 -2539701 -5153384 -1678169 660550 243851 730430 -984029 -983245 -1426672 -2080017 -148088 -28497000 -28186 -8725
Earnings Per Share (EPS) -23.35 -7.63 -7.58 -4.99 -1.04 0.0233 0.81 -3.35 -0.74 -6.3 -13.5 -0.97 -273.59 -0.27 -0.11
Diluted Earnings Per Share -7.49 -7.63 -7.58 -4.99 -1.04 0.0233 0.81 -3.6 -0.9 -6.07 -13.35 -0.97 -269.45 -0.27 -0.11
Weighted Average Shares Outstanding 764058 564863 542450 513708 395273 388430 355060 349641 349641 319371 154909 154909 104160 105760 81199
Diluted Weighted Average Shares Outstanding 2381443 564863 542450 513708 395273 388428 378736 350499 349641 331456 156685 154909 105760 105760 81199

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.